Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of nicotine on smooth pursuit eye movements in healthy non-smokers.
Meyhöfer I, Kasparbauer AM, Steffens M, Ettinger U. Meyhöfer I, et al. Among authors: ettinger u. Psychopharmacology (Berl). 2019 Jul;236(7):2259-2271. doi: 10.1007/s00213-019-05223-1. Epub 2019 Mar 14. Psychopharmacology (Berl). 2019. PMID: 30874860 Clinical Trial.
Effects of procyclidine on eye movements in schizophrenia.
Ettinger U, Kumari V, Zachariah E, Galea A, Crawford TJ, Corr PJ, Taylor D, Das M, Sharma T. Ettinger U, et al. Neuropsychopharmacology. 2003 Dec;28(12):2199-208. doi: 10.1038/sj.npp.1300286. Neuropsychopharmacology. 2003. PMID: 12942142 Clinical Trial.
Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy.
Petrovsky N, Ettinger U, Quednow BB, Walter H, Schnell K, Kessler H, Mössner R, Maier W, Wagner M. Petrovsky N, et al. Among authors: ettinger u. Psychopharmacology (Berl). 2012 May;221(1):27-38. doi: 10.1007/s00213-011-2540-9. Epub 2011 Oct 29. Psychopharmacology (Berl). 2012. PMID: 22038536 Free article. Clinical Trial.
Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls.
Petrovsky N, Ettinger U, Quednow BB, Landsberg MW, Drees J, Lennertz L, Frommann I, Heilmann K, Sträter B, Kessler H, Dahmen N, Mössner R, Maier W, Wagner M. Petrovsky N, et al. Among authors: ettinger u. Int J Neuropsychopharmacol. 2013 Aug;16(7):1473-81. doi: 10.1017/S1461145713000011. Epub 2013 Feb 11. Int J Neuropsychopharmacol. 2013. PMID: 23399382 Free article. Clinical Trial.
Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy.
Schmechtig A, Lees J, Grayson L, Craig KJ, Dadhiwala R, Dawson GR, Deakin JF, Dourish CT, Koychev I, McMullen K, Migo EM, Perry C, Wilkinson L, Morris R, Williams SC, Ettinger U. Schmechtig A, et al. Among authors: ettinger u. Psychopharmacology (Berl). 2013 May;227(2):331-45. doi: 10.1007/s00213-013-2973-4. Epub 2013 Feb 22. Psychopharmacology (Berl). 2013. PMID: 23430159 Clinical Trial.
The effect of nicotine on sensorimotor gating is modulated by a CHRNA3 polymorphism.
Petrovsky N, Ettinger U, Kessler H, Mössner R, Wolfsgruber S, Dahmen N, Maier W, Wagner M, Quednow BB. Petrovsky N, et al. Among authors: ettinger u. Psychopharmacology (Berl). 2013 Sep;229(1):31-40. doi: 10.1007/s00213-013-3081-1. Epub 2013 Apr 19. Psychopharmacology (Berl). 2013. PMID: 23604333 Free article. Clinical Trial.
205 results